Prof. HATİCE YASEMİN BALABAN

BALABAN H. Y., AKA C., KOCA ÇALIŞKAN U.

Kanser Gündemi , vol.5, no.3, pp.33-40, 2017 (TRDizin)

66. Liver immunology and herbal treatment

WORLD JOURNAL OF HEPATOLOGY , vol.9, no.17, pp.757-770, 2017 (Scopus)

67. Alkol-Dışı Yağlı Karaciğer HastalığınınGüncel Tedavisinde Metformin ve UDKA’nınTemel veya Yardımcı Ajan Olarak Yeri Var mıdır?Ufuktaki Yeni Tedavi Ajanları Nelerdir?

Balaban Y. H., ŞİMŞEK H., TATAR G.

gÜncel gastroenteroloji , 2017 (Non Peer-Reviewed Journal)

68. Intrahepatic Cholestasis of Pregnancy: Spontaneous vs in vitro Fertilization

BÖLÜKBAŞ F. F., BÖLÜKBAŞ C., BALABAN H. Y., İĞNAK S., aygün c., ergül e., et al.

Euroasian Journal of Hepato-Gastroenterology , vol.7, no.2, pp.126-129, 2017 (Peer-Reviewed Journal)

69. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity

AYGÜN C., YILDIRIM ALTINOK A., ÇAKIR A., AĞAN A. F., BALABAN H. Y.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.79, no.4, pp.487-489, 2016 (SCI-Expanded, Scopus) Sustainable Development

70. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity

AYGÜN C., YILDIRIM ALTINOK A., ÇAKIR A., AĞAN A. F., Balaban Y.

ACTA GASTRO-ENTEROLOGICA BELGICA , vol.79, no.3, pp.363-365, 2016 (SCI-Expanded, Scopus) Sustainable Development

71. Gastric cancer prevention from the point of helicobacter

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.25, no.4, pp.463-467, 2014 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

72. Mature ovarian teratoma as a possible cause of fever and clinical exacerbation in Behçet’xxs disease: a case report

MODERN RHEUMATOLOGY , vol.11, no.2, pp.172-175, 2014 (SCI-Expanded, Scopus)

73. Detection of Resistance Mutations in Chronic Hepatitis B Patients Receiving Antiviral Therapy for Over One Year

AYDOĞAN S., ERGÜNAY K., Balaban Y., ALP A., Simsek H., TATAR G., et al.

MIKROBIYOLOJI BULTENI , vol.47, no.3, pp.472-481, 2013 (SCI-Expanded, Scopus, TRDizin)

74. Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year] Bir Yıldan Uzun Süreli Antiviral İlaç Kullanan Kronik Hepatit B Hastalarında Direnç Mutasyonlarının Saptanması

Mikrobiyol Bul , vol.47, pp.472-481, 2013 (TRDizin)

75. Alpha-1 antitrypsin deficiency in patients with chronic hepatitis

Şımşek H., Pinar A., Altinbaş A., Alp A., Balaban Y., Büyükaşik Y., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.5, pp.569-573, 2012 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

76. Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis

ERGÜNAY K., Balaban Y., Cosgun E., Alp A., ŞİMŞEK H., Sener B., et al.

ANNALS OF HEPATOLOGY , vol.11, no.5, pp.672-678, 2012 (SCI-Expanded, Scopus) Sustainable Development

77. **The genotype frequencies of IL28B polymorphisms (rs12979860, rs8099917) among Turkish patients with hepatitis C**

Simsek H., ALP A., Yilmaz B., Balaban Y. H., ALTUN B., UZUN Ö., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , vol.24, no.9, pp.1113-1115, 2012 (SCI-Expanded, Scopus) Sustainable Development

78. Mapping of Microsatellite Instability in Endoscopic Normal Colon

TUĞ E., BALABAN H. Y., ŞAHİN E.

GENETIC TESTING AND MOLECULAR BIOMARKERS , vol.16, no.5, pp.388-395, 2012 (SCI-Expanded, Scopus) Sustainable Development

79. A key problem and challenge for hepatology: Obesity-related metabolic liver diseases

Balaban Y. H.

WORLD JOURNAL OF HEPATOLOGY , vol.3, no.6, pp.142-146, 2011 (ESCI, Scopus) Sustainable Development

80. Cutoff Level to Detect Heterozygous Alpha 1 Antitrypsin Deficiency in Turkish Population

ŞİMŞEK H., PINAR A., Altinbas A., Alp A., Balaban Y. H., BÜYÜKAŞIK Y., et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.25, no.4, pp.296-299, 2011 (SCI-Expanded, Scopus)

81. **Do Gene Expressions Differ Between Gastritis with and without Helicobacter pylori?**

Boran C., BALABAN H. Y., Yilmaz F.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.30, no.6, pp.1806-1813, 2010 (SCI-Expanded, Scopus) Sustainable Development

82. The preventive effect of low molecular weight heparin on CCL₄-induced necrosis and apoptosis in rat liver

KÜKNER A., TÖRE F., FIRAT T., TERZİ E. H., ÖNER H., Balaban Y. H., et al.

ANNALS OF HEPATOLOGY , vol.9, no.4, pp.445-454, 2010 (SCI-Expanded, Scopus) Sustainable Development

83. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction

Ozhan H., BALABAN H. Y.

HEART , vol.96, no.10, pp.791, 2010 (SCI-Expanded, Scopus) Sustainable Development

84. Helicobacter pylori’nin Eşlik Ettiği ve Etmediği Gastritlerde Gen Ekspresyonları Farklı mıdır?

Turkiye Klinikleri J Med Sci , vol.30, no.6, pp.1806-1813, 2010 (TRDizin)

85. Clinical utility of capsule endoscopy in small intestinal diseases, experience of single referral center with 125 cases

KAV T., Shorbagi A. I., SİVRİ B., Balaban Y. H., Arslan S., Batman F., et al.

PRZEGLAD GASTROENTEROLOGICZNY , vol.4, no.5, pp.245-250, 2009 (SCI-Expanded, Scopus) Sustainable Development

86. The power suction maneuver in single-balloon enteroscopy

Kav T., Balaban Y., Bayraktar Y.

ENDOSCOPY , vol.40, no.11, pp.961-962, 2008 (SCI-Expanded, Scopus) Sustainable Development

87. Causes of hypouricemia among outpatients

BUĞDAYCI G., Balaban Y., Sahin O.

LABMEDICINE , vol.39, no.9, pp.550-552, 2008 (SCI-Expanded, Scopus) Sustainable Development

88. What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?

ŞİMŞEK H., Shorbagi A., Balaban Y., TATAR G.

JOURNAL OF HEPATOLOGY , vol.49, no.3, pp.464-465, 2008 (SCI-Expanded, Scopus) Sustainable Development

89. Tumor markers in familial Mediterranean fever and their correlation with the frequency of attacks

Balaban Y. H., Simsek H., Yilmaz R., Sarer-Yurekli B. P., Shorbagi A., Tatar G.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.4, 2008 (SCI-Expanded, Scopus) Sustainable Development

90. Dipeptidyl peptidase IV (DDP IV) in NASH patients

Balaban Y. H., KORKUSUZ P., Simsek H., Gokcan H., Gedikoglu G., Pinar A., et al.

ANNALS OF HEPATOLOGY , vol.6, no.4, pp.242-250, 2007 (SCI-Expanded, Scopus) Sustainable Development

91. The difference in cyclin D1, HSP 105, EGFR, RB, and MSH2 gene expressions in chronic gastritis with and without helicobacter pylori infection

Boran C., Balaban Y., Yilmaz F.

VIRCHOWS ARCHIV , vol.451, no.2, pp.318-319, 2007 (SCI-Expanded, Scopus)

92. Solitary lipomatous polyp or lipoma of gastrointestinal tract: 3 case reports

Yilmaz F., Balaban Y. H., Sengul N., Boran C.

VIRCHOWS ARCHIV , vol.451, no.2, pp.328, 2007 (SCI-Expanded, Scopus)

93. Multinodular leiomyoma of the esophagus with internodular hydropic degeneration and bulbous serosal protrusions similar to cotyledonoid uterine leiomyoma

Boran C., Sengul N., BALABAN H. Y., Guerel S.

DISEASES OF THE ESOPHAGUS , vol.20, no.2, pp.187-189, 2007 (SCI-Expanded, Scopus) Sustainable Development

94. Wilson Hastalığı: Olgu Sunumu

Dicle Tıp Dergisi , vol.34, pp.57-60, 2007 (Non Peer-Reviewed Journal)

95. HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis

Simsek H., Balaban Y. H., Sumer H., Yilmaz E., Tatar G.

DIGESTIVE DISEASES AND SCIENCES , vol.51, no.10, pp.1723-1724, 2006 (SCI-Expanded, Scopus) Sustainable Development

96. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients

Simsek H., Balaban Y., Yilmaz E., Sumer H., Buyukasik Y., Cengiz C., et al.

ANNALS OF HEMATOLOGY , vol.84, no.10, pp.646-649, 2005 (SCI-Expanded, Scopus) Sustainable Development

97. **Alarming clarithromycin resistance of Helicobacter pylori in Turkish population**

Simsek H., Balaban Y., Gunes D., Hascelik G., Ozarslan E., Tatar G.

HELICOBACTER , vol.10, no.4, pp.360-361, 2005 (SCI-Expanded, Scopus) Sustainable Development

98. Coincidence or causality:: Celiac and Crohn diseases in a case of Turner syndrome

Durusu M., Gurlek A., Simsek H., Balaban Y., Tatar G.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , vol.329, no.4, pp.214-216, 2005 (SCI-Expanded, Scopus) Sustainable Development

99. Familial Mediterranean fever (FMF) in Turkey - Results of a nationwide multicenter study

Tunca M., Akar S., Onen F., Ozdogan H., KASAPÇOPUR Ö., Yalcinkaya F., et al.

MEDICINE , vol.84, no.1, pp.1-11, 2005 (SCI-Expanded, Scopus) Sustainable Development

100. Celiac disease in the Turkish population

Elsurer R., Tatar G., Simsek H., Balaban Y., Aydinli M., Sokmensuer C.

DIGESTIVE DISEASES AND SCIENCES , vol.50, no.1, pp.136-142, 2005 (SCI-Expanded, Scopus) Sustainable Development

101. Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population

Tatar G., Elsurer R., Simsek H., Balaban Y., Hascelik G., Ozcebe O., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.49, no.9, pp.1479-1484, 2004 (SCI-Expanded, Scopus) Sustainable Development

102. Frequency of HFE mutations among Turkish blood donors according to transferrin saturation

Simsek H., Sumer H., Yilmaz E., Balaban Y., Ozcebe O., Hascelik G., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.38, no.8, pp.671-675, 2004 (SCI-Expanded, Scopus) Sustainable Development

103. Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis

Kadayifcilar S., Gedik S., Eldem B., Balaban H. Y., Kansu T.

OCULAR IMMUNOLOGY AND INFLAMMATION , vol.12, no.2, pp.153-157, 2004 (SCI-Expanded, Scopus)

104. Ameboma mimicking carcinoma of the cecum:: case report

Simsek H., Elsurer R., Sokmensuer C., Balaban H. Y., Tatar G.

GASTROINTESTINAL ENDOSCOPY , vol.59, no.3, pp.453-454, 2004 (SCI-Expanded, Scopus) Sustainable Development

105. Ekstra-özefageal Reflü Hastalığı

Hacettepe Tıp Dergisi , vol.35, pp.3-6, 2004 (TRDizin)

106. Diagnostic and therapeutic ERCP in hepatic hydatid disease

Simsek H., Ozaslan E., Sayek I., Savas C., Abbasoglu O., Soylu A., et al.

GASTROINTESTINAL ENDOSCOPY , vol.58, no.3, pp.384-389, 2003 (SCI-Expanded, Scopus) Sustainable Development

107. Successful Weaning After Plasmapheresis Performed in a Patient with Myasthenic Crisis Proveked by Listeria Meningoencephalitis

BALABAN H. Y., TOKGÖZOĞLU S. L., AYGÜN S.

Turk Respir J , vol.2, pp.44-46, 2001 (TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences 48

1. Radgohar, A; Burus, A; Ucdal, M; Yalcinkaya, A; Balaban, Y; Celtikci, B. Evaluation of the molecular basis of autoimmune cholestatic liver diseases via serum cytokine release. FEBS OPEN BIO. 2025; 15 (Supp2), 450-451Meeting Abstract LB-R-41-07

BALABAN H. Y., BURUŞ A., ÜÇDAL M., ÇELTİKÇİ B.

FEBS OPEN BIO, United States Of America, 01 December 2025, (Full Text)

2. Karaciğer Sağlığı Bilgi ve Farkındalık Düzeyi

BALABAN H. Y., TAŞKESEN İ., ÇAKMAK M. F., güniz Dogan b., ŞİMŞEK C.

ugh2025, Turkey, 25 - 30 November 2025, (Full Text)

3. Üniversite Öğrencilerinde Karaciğer Hastalıklarına Yönelik Damgalayıcı Tutumlar

BALABAN H. Y., TAŞKESEN İ., TAŞKESEN B., güniz Dogan b., ŞİMŞEK C., PARLAR Y. E.

ugh2025, Turkey, 25 - 30 November 2025, (Full Text)

4. Fonksiyonel Kabızlıkta Abdominal Masaj ile Birlikte Aerobik Egzersiz Eğitiminin Etkileri: Randomize Kontrollü Çalışma

DOĞAN İ. G., BALABAN H. Y., AKBAYRAK T., ŞİMŞEK C., ÖZGÜL S.

UGH2025, 25 - 30 November 2025, (Full Text)

5. PATIENT CHARACTERISTICS OF ADULT CYSTIC FIBROSIS LIVER DISEASE AND THE EFFECTIVENESS OF NONINVASIVE FIBROSIS TESTS IN DETERMINING DISEASE STATUS

BALABAN H. Y., KAV T.

aasld2025, United States Of America, 7 - 11 November 2025, (Full Text)

6. THE ROLE OF KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) GENE VARIANTS IN AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CHOLANGITIS: ASSOCIATION WITH DISEASE SEVERITY AND DEEP REMISSION

BALABAN H. Y., ÜÇDAL M., BURUŞ A., DAĞ O.

aasld2025, United States Of America, 7 - 11 November 2025, (Full Text)

7. DIRECT BILIRUBIN-BASED MELD SCORE: IMPACT OF HEPATIC VS. EXTRA-HEPATIC HYPERBILIRUBINEMIA ON STAGING OF CIRRHOSIS

BALABAN H. Y., ÜÇDAL M., ŞENDUR İ., DAĞ O.

aasld2025, United States Of America, 7 - 11 November 2025, (Full Text)

8. IMPACT OF A SUPERVISED COMBINED EXERCISE PROGRAM ON QUALITY OF LIFE IN PATIENTS WITH MASH: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL

BALABAN H. Y., KUMBAROĞLU F. B., KARÇAALTINCABA M., PINAR A., KIZIL M., PARLAR Y. E., et al.

ueg2025, Germany, 4 - 07 October 2025, (Full Text)

9. MULTI-AGENT LLM APPROACH VERSUS SINGLE MODEL IN THE MANAGEMENT OF NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING

BALABAN H. Y., ŞİMŞEK C., DURAK M. B., ÜÇDAL M.

ueg2025, Germany, 4 - 07 October 2025, (Full Text)

10. ROLE OF NUCLEAR RECEPTOR COACTIVATOR 4 (NCOA4) GENE VARIANTS IN METABOLIC HYPERFERRITINEMIA OBSERVED IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)

BALABAN H. Y., ÜÇDAL M., ŞİMŞEK C., BURUŞ A., ÇELTİKÇİ B.

eug2025, Germany, 4 - 07 October 2025, (Full Text)

11. The role of flow-mediated dilation in assessing cardiovascular risk among patients with non-alcoholic fatty liver disease: A retrospective study

EAS2025, England, 4 - 07 May 2025, (Full Text)

12. MASLD Tanılı Hastalarda Kombine Egzersiz Programının Yaşam Kalitesi Üzerine Etkisi: Erken Sonuçlar

KUMBAROĞLU F. B., BALABAN H. Y., DÜGER T.

19. ULUSLARARASI FİZYOTERAPİDE GELİŞMELER KONGRESİ, Ankara, Turkey, 09 April 2025, (Summary Text)

13. The Cytokine Profile of Primary Biliary Cholangitis (PBC): Is PBC an Autoinflammatory vs. Autoimmune Disease?

RADGOHAR A., ÜÇDAL M. T., BURUŞ A., YALÇINKAYA A., BALABAN H. Y., ÇELTİKÇİ B.

41. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 27 November 2024, (Summary Text)

14. A Comprehensive Study on Gastroenterologists’ Beliefs, Attitudes, And Knowledge of Physical Activity and Exercise

KUMBAROĞLU F. B., DÜGER T., ÖZDEMİR P., BALABAN H. Y.

UEG Week, Viyana, Austria, 12 - 15 October 2024, (Summary Text)

15. Alkolsüz steatohepatit hastalarında yaşam kalitesi, yorgunluk, duygudurum ve hastalık belirteçleri arasındaki ilişkinin araştırılması.

KUMBAROĞLU F. B., BALABAN H. Y., DÜGER T.

9. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Denizli, Turkey, 26 October 2023, no.55, (Summary Text)

16. IS HIGH AFP ASSOCIATED WITH LIVER DISEASES IN AUTOSOMAL RECESSIVE CEREBELLAR ATAXIAS?

BALABAN H. Y., YALÇIN ÇAKMAKLI G., ELİBOL B.

31st United European Gastroenterology Week 2023, viyana, Austria, 12 - 15 October 2023, (Full Text)

17. Wilson Hastalığı Tedavisinde Serum Değişken ve Göreceli Değişken Bakır Testleri 24 Saatlik İdrar Bakır Atılımına Alternatif Olabilir mi?

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., ŞAHİN T., ELİBOL B., DAĞ O.

39. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 22 November 2022, (Summary Text)

18. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER CORRELATE WITH MULTIPARAMETRIC LIVER MRI PARAMETERS IN PATIENTS WITH WILSON DISEASE

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., İDİLMAN İ. S., ŞAHİN T., PINAR A., et al.

AASLD, Washington, Kiribati, 10 November 2022, vol.76, pp.1119-1120, (Summary Text)

19. CAN SERUM EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER BE ALTERNATIVE TESTS TO 24-HOUR URINARY COPPER EXCREATION IN PATIENTS ON TREATMENT FOR WILSON DISEASE?

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PINAR A., ELİBOL B.

AASLD 2022, United States Of America, 10 November 2022, vol.76, pp.1117, (Summary Text)

20. EXCHANGEABLE AND RELATIVE EXCHANGEABLE COPPER LEVELS WERE SIMILAR IN WILSON DISEASE PATIENTS WITH AND WITHOUT OF CRANIAL MRI INVOLMENT

BALABAN H. Y., DURUKAN B. M., YALÇIN ÇAKMAKLI G., PARLAK Ş., ŞAHİN T., PINAR A., et al.

AASLD, Washington, Kiribati, 10 November 2022, vol.76, pp.1120-1121, (Summary Text)

21. Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy

BALABAN H. Y., GÖKCAN H., YAPALI S., AKDOĞAN KAYHAN M., ŞİMŞEK H., İDİLMAN R.

EASL, Londrina, Brazil, 23 June 2022, vol.77, pp.858, (Summary Text)

22. Trends and causes of etiology in adult liver transplant patients: multicenter study

BALABAN H. Y., HARPUTLUOĞLU M. M. M., AKYILDIZ N. M., TURAN İ., GÜNŞAR F., KARASU A. Z., et al.

EASL, Londrina, Brazil, 23 June 2022, vol.77, pp.820, (Summary Text)

23. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study

BALABAN H. Y., GÖKCAN H., YAPALI S., GÜZELBULUT F., AKDOĞAN KAYHAN M., KIYICI M., et al.

EASL, Londrina, Brazil, 23 June 2022, vol.77, pp.861, (Summary Text)

24. Ayar, ŞN., Soyak, E., Şimşek, C., Çağdaş Ayvaz, DN., Balaban, Y. “Otoimmun Karaciğer Hastalarının Primer İmmün Yetmezlik Yönünden Değerlendirilmesi,” 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi - ONLINE KONGRE, SS – 031, 25-29 Kasım 2020.

37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi - ONLINE KONGRE, Turkey, 25 - 29 November 2020, (Full Text)

25. Melekoglu Ellik, Z., Idilman, IS., Caliskan KartaL, A., Balaban, YH., karcaaltincaba, M., “Magnetic Resonance Elastography and Transient Elastograpghy to Assess Hepatic Stetaosis and Liver Fibrosis in the Liver Transplant Setting,” Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Electronic Network, NOV 13-16, 2020, ‏Hepatology,Vol. 72, Suppl 1 773A: Abstract 1289, 2020.

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) Electronic Network, 13 - 16 November 2020

26. MAGNETIC RESONANCE ELASTOGRAPHY AND TRANSIENT ELASTOGRAPGHY TO ASSESS HEPATIC STETAOSIS AND LIVER FIBROSIS IN THE LIVER TRANSPLANT SETTING

Ellik Z. M., İDİLMAN İ. S., KARTAL A. Ç., Balaban Y. H., KARÇAALTINCABA M., İDİLMAN R.

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 November 2020, vol.72, (Summary Text)

27. Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experience

TURAN İ., ALADAĞ M., HARPUTLUOĞLU M. M. M., YILMAZ S., GENÇDAL G., POLAT K. Y., et al.

The Digital International Liver Congress (EASL) 2020, 27 - 29 August 2020, vol.73, pp.227, (Summary Text)

28. Proceedings of the World Congress of Gastroenterology

BALABAN H. Y., ASLAN A. T., AKDOĞAN KİTTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.

World Congress of Gastroenterology, İstanbul, Turkey, 21 September 2019, vol.30, pp.729, (Summary Text)

29. Hepatitis E virus epidemiology of patients with chronic hepatitis C in Turkey

BALABAN H. Y., ASLAN A. T., AKDOĞAN F. N., ALP A., DAĞ O., AYAR Ş. N., et al.

World Congress of Gastroenterology 2019, 21 - 24 September 2019, (Summary Text)

30. The efficacy of abdominal massage in functional constipation: A randomized placebo-controlled trial

DOĞAN İ. G., ORHAN C., AKBAYRAK T., BALABAN H. Y., VAHABOV C., ÜZELPASACI E., et al.

World Congree of Gastroenterology 2019, 21 - 24 September 2019, vol.30, pp.725-726, (Summary Text)

31. Hepatitis B virus screening and immunization rates in special risk groups.

BALABAN H. Y., ASLAN A. T., AKDOĞAN F. N., ALP A., DAĞ O., AYAR Ş. N., et al.

World Congress of Gastroenterology 2019, 21 - 24 September 2019, (Summary Text)

32. Hepatitis B virus screening and immunization rates in special risk groups

World Congress of Gastroenterology, İstanbul, Turkey, 01 January 2019 Sustainable Development

33. Hepatitis E virus epidemiology of patients with chronic hepatitis C in Turkey

World Congress of Gastroenterology, İstanbul, Turkey, 01 January 2019 Sustainable Development

34. Hepatitis E Virus Epidemiology and Genotype Analysis Among Special Risk Groups in Turkey, 16. Ulusal Hepato Gastroenteroloji Kongresi, 17-23 Ekim 2019-Girne, KKTC.

ASLAN A. T., BALABAN H. Y., AYAR Ş. N., AKDOĞAN KİTTANA F. N., ALP A., Vahabov C., et al.

16. Ulusal Hepato Gastroenteroloji Kongresi, Girne, Cyprus (Kktc), 31 October 2018, (Summary Text) Sustainable Development

35. Hepatitis C Awareness Survey: Retrospective Evaluation of HCV Tests between 2000-2017

Balaban Y. H., DAĞ O., Alp A., PÜRNAK T., GÖKTAŞ M. A., Tseveldor N., et al.

Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San-Francisco, Costa Rica, 9 - 13 November 2018, vol.68, (Summary Text)

36. Antiviral ilaç tedavisi alan kronik hepatit B hastalarında Entekavir ve Tenofovir direnç mutasyonlarının araştırılması

AYDOĞAN S., ERGÜNAY K., BALABAN H. Y., ALP A., ŞİMŞEK H., TATAR G., et al.

1. Ulusal Klinik Mikrobiyoloji Kongresi, Turkey, 12 - 16 November 2011, pp.59 Sustainable Development

37. THE THERAPEUTIC EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON CCL₄-INDUCED NECROSIS AND APOPTOSIS IN RAT LIVER

Kukner A., Tore F., Firat T., Terzi E. H., Oner H., Balaban Y., et al.

45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 14 - 18 April 2010, vol.52, (Summary Text)

38. Kronik karaciğer hastalarında alfa 1 antitripsin eksikliği

7. Ulusal Hepatoloji Kongresi, Turkey, 01 January 2009

39. Metabolic Syndrome, NASH and Hepatocyte Growth Factor

13th United European Gastroenterology Week (UEGW), Kopenak, 01 January 2005

40. Kolon Kanserini Taklit Eden Bir Ameboma Vakası Kolonoskopi Cerrahiden Kurtarabilir mi?

I. Hepato Gastroenteroloji Kongresi, Turkey, 01 January 2004 Sustainable Development

41. Is CD26 (Dipeptidyl Peptidase IV) a Novel Candidate For Controlling NASH Pathogenesis?

12th United European Gastroenterology Week (UEGW), prag, 01 January 2004

42. Kapsul Endoskopide Klinik Deneyimimiz: 4 Olgunun Sunumu

VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaijan, 01 January 2003

43. Benign özefagus darliklarinin endoskopik tedavisi

VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaijan, 01 January 2003

44. The Screening of Tissue Transglutaminase Antibody in Healty Blood Donors for the Celiac Disease Screening in Turkish Population

4th Congress of European Federation of Internal Medicine, Berlin, Germany, 01 January 2003

45. Celiac Disease in Turkish Population

4th Congress of European Federation of Internal Medicine, Berlin, Germany, 01 January 2003

46. Son Bir Yillik ERCP Sonuçlarinin Önceki Yillarla Karşilaştirilması

VI International Euroasian and Azerbaijanian Congress of Qastroenterologists and Surgeons, Baku, Azerbaijan, 01 January 2003

47. Association of Helicobacter Pylori Infection with Familiar Mediterranean Fever Disease

3rd International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 01 January 2002

48. Genotype Screening for Hereditary Hemochromatosis Among Voluntary Blood Donors in Turkey